Table 2 Summary of reported cases of primary intramedullary spinal cord lymphoma
Entry | Ratio (%) |
|---|---|
Pathologic type | |
B cell | 12/17 (71) |
T cell | 5/17 (29) |
Treatment | |
Surgery, chemotherapy and radiation | 3/20 (15) |
Surgery and chemotherapy | 1/20 (5) |
Surgery and radiation | 2/20 (10) |
Chemotherapy and radiation | 10/20 (50) |
Chemotherapy | 2/20 (10) |
Radiation | 1/20 (5) |
Surgery Prognosis | 1/20 (5) |
1-year survival | 9/12 (75) |
2-year survival | 5/12 (42) |
3-year survival | 3/12 (25) |
4-year survival | 3/12 (25) |